Understanding Human Primary Atopic Disorders
Understanding Human Primary Atopic Disorders
批准号:
443565
负责人:
Turvey Stuart E
金额:
$55.73万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
未结题
起止时间:
2021-04-01 至 2026-04-01
中文摘要
近三分之一的加拿大人患有过敏性疾病,如哮喘、食物过敏和湿疹。在全球范围内,仅哮喘一项就影响了大约3亿人,全球每年的损失超过200亿美元。解决这一过敏症健康危机的方法
英文摘要
Nearly 1-in-3 Canadians suffer from an allergic disease, such as asthma, food allergy and eczema. Globally, asthma alone affects an estimated 300 million people, with annual costs over $20 billion dollars worldwide. Solutions to this allergy health crisis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harnessing early life developmental trajectories and the gut microbiota to identify new ways to prevent asthma and obesity.
-
批准号:472653
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:Turvey Stuart E
-
依托单位:
Understanding Human Primary Atopic Disorders
-
批准号:431803
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2020
-
负责人:Turvey Stuart E
-
依托单位:
Canada Research Chair Tier 1
-
批准号:392587
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2018
-
负责人:Turvey Stuart E
-
依托单位:
Programmatic research to understand how modifiable environmental factors interact with the genome in the development of asthma.
-
批准号:324095
-
项目类别:Operating Grants
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Turvey Stuart E
-
依托单位:
Programmatic research to understand how modifiable environmental factors interact with the genome in the development of asthma.
-
批准号:339821
-
项目类别:Operating Grants
-
资助金额:$122.06万
-
财政年份:2015
-
负责人:Turvey Stuart E
-
依托单位:
Understanding the Novel Human Primary Immunodeficiency Caused by MALT1 Mutations
-
批准号:291119
-
项目类别:Operating Grants
-
资助金额:$29.24万
-
财政年份:2013
-
负责人:Turvey Stuart E
-
依托单位:
Development of a TLR5 antagonist as a novel anti-inflammatory therapy for cystic fibrosis
-
批准号:188108
-
项目类别:Operating Grants
-
资助金额:$10.93万
-
财政年份:2009
-
负责人:Turvey Stuart E
-
依托单位:
国内基金
海外基金
Journal of Genetics and Genomics
-
批准号:31224803
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:于昕
-
依托单位: